Comparing rates of recurrent infection for first occurrence of <i>Clostridioides difficile</i> between tapered oral vancomycin and standard vancomycin: a retrospective, propensity matched cohort study
Larger prospective trials are needed to elucidate the clinical utility of tapered oral vancomycin as a treatment option to achieve sustained clinical cure in first occurrences of CDI.
Authors
- Ashley M Wilde (ORCID: https://orcid.org/0000-0001-8459-0025)
- Martin Brenneman (ORCID: https://orcid.org/0000-0001-9515-7139)
- Matthew Song (ORCID: https://orcid.org/0000-0001-8634-6421)
- Thomas Chandler (ORCID: https://orcid.org/0000-0002-2284-6213)
- Elena A. Swingler (ORCID: https://orcid.org/0000-0003-4288-955X)
- Sarah E Moore (ORCID: https://orcid.org/0000-0002-3382-2735)
- Derek K. Smith (ORCID: https://orcid.org/0000-0001-6323-8700)
- Stephen Furmanek (ORCID: https://orcid.org/0000-0001-9112-2860)
Institutions
- Norton Healthcare (US)
Publication Details
- Journal
- Infection Control and Hospital Epidemiology
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1017/ice.2024.117
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.00